Ovation Science Inc. (OVATF)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in CAD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CAD m | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Operating profit | CAD m | -1 | -1 | ||||||
| Net profit | CAD m | -1 | -2 | -1 | -1 | -0 | -1 | -1 | - |
| EPS reported | CAD | -0.02 | -0.02 | ||||||
| Operating cashflow per share | CAD | -0.00 | -0.00 | ||||||
| Capex per share | CAD | 0.00 | 0.00 | ||||||
| FCF per share | CAD | -0.00 | -0.00 | ||||||
| Free cash flow | CAD m | -0 | -0 | ||||||
| Net debt | CAD m | 0 | 0 | ||||||
| Book value equity | CAD m | -1 | -2 | ||||||
| Book value per share | CAD | -0.04 | -0.04 | ||||||
| Number of shares | m | 35.6 | 38.44 | ||||||
| DPS (TTM paid) | CAD | 0.00 | 0.00 |
Financial summary
Financials in CAD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | -0.99 | -0.91 | ||||||
| P/S LTM | x | 21.25 | 21.89 | ||||||
| P/FCF LTM | x | -18.87 | -12.38 | ||||||
| EV/EBITDA LTM | x | -2.76 | -2.80 | ||||||
| EV/Sales LTM | x | 24.35 | 13.47 | ||||||
| Earnings Yield LTM | % | -43.77% | -79.96% | ||||||
| FCF Yield | % | -5.30% | -8.08% | ||||||
| Quality | |||||||||
| ROE | % | +43.26% | +42.69% | ||||||
| ROIC | % | +50.87% | +45.23% | ||||||
| Operating margin | % | -8.81% | -8.94% | ||||||
| Gross margin | % | -4.60% | -2.46% | ||||||
| FCF/Sales | % | -112.60% | -176.97% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -40.09% | -41.86% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -0.27 | -0.40 | ||||||
| Net Debt/EBITDA | x | -0.35 | -0.43 | ||||||
| EBIT/Net interest | x | -11.88 | -15.94 | ||||||
| Net debt/market cap | % | +19.63% | +45.02% | ||||||
| Net debt/Equity | x | -0.14 | -0.16 | ||||||
| Gross debt/equity | x | -0.19 | -0.18 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Ovation Science Inc. specializes in the manufacturing of cannabis and hemp-derived products, distributing them across Canada, the United States, and Mexico. Central to its operations is Invisicare, a proprietary, patented drug delivery system. This advanced technology is incorporated into topical and transdermal skincare products, which feature hemp seed oil and cannabis, and are marketed under the Ovation and BASKiN brands. Beyond this core technology, the company offers a range of other solutions: health and wellness products infused with cannabidiol (CBD) under the Invibe MD name, CBD-focused skincare solutions branded as ARLO CBD, and hand sanitizers known as DermSafe. Furthermore, Ovation Science Inc. possesses various sublicenses for cannabis-related offerings and oversees the Lighthouse platform, which caters to licensed dispensaries throughout the United States. The firm was established in 2017 and maintains its primary corporate offices in Vancouver, Canada.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Ovation Science Inc. specializes in the manufacturing of cannabis and hemp-derived products, distributing them across Canada, the United States, and Mexico. Central to its operations is Invisicare, a proprietary, patented drug delivery system. This advanced technology is incorporated into topical and transdermal skincare products, which feature hemp seed oil and cannabis, and are marketed under the Ovation and BASKiN brands. Beyond this core technology, the company offers a range of other solutions: health and wellness products infused with cannabidiol (CBD) under the Invibe MD name, CBD-focused skincare solutions branded as ARLO CBD, and hand sanitizers known as DermSafe. Furthermore, Ovation Science Inc. possesses various sublicenses for cannabis-related offerings and oversees the Lighthouse platform, which caters to licensed dispensaries throughout the United States. The firm was established in 2017 and maintains its primary corporate offices in Vancouver, Canada.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free